Trademark Overview
On Monday, October 14, 2024, a trademark application was filed for EUREKA INTERNATIONAL GROUP with the United States Patent and Trademark Office. The USPTO has given the EUREKA INTERNATIONAL GROUP trademark a serial number of 98800327. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, March 25, 2025. This trademark is owned by Eureka Biotech Inc.. The EUREKA INTERNATIONAL GROUP trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Transportation & Storage Services, and Computer & Software Services & Scientific Services categories with the following description:
freight logistics management; freight forwarding; freight brokerage; freight transportation brokerage; cargo handling; cargo transportation; warehouse storage; rental of warehouse space; warehousing services; warehousing information
real estate development; real estate sales management; real estate brokerage services; insurance brokerage services; financial services, namely, real estate brokerage services and mortgage brokerage services; real estate services, namely, rental property management; real estate consultation; consultation in the field of finance; Financial consulting services, namely, expert analysis in finance; fund investment consultation; venture capital fund management; head fund management; financial services; investment advice; funds investments; investment consultation; investment management; investment brokerage
business consultation services; business consulting and business information for enterprises; business consulting and information services; business consulting in the consumer products industry; business consulting services for digital transformation; business marketing services; digital marketing services; business marketing consultation services; advertising services; digital advertising services; business management and consultation services in the field of real estate and insurance
scientific research in the field of organoid technology; drug screening for scientific research purposes; stem cell research services